Sector Chart Dimerix Limited

Stocks

DXB

AU000000DXB7

Biotechnology & Medical Research

Market Closed - Australian S.E. 01:10:10 2026-10-19 EDT			5-day change	1st Jan Change
0.2100 ^AUD	-4.55%		-4.55%	-61.82%

11:16pm	Dimerix Chair to Retire	MT
10-15	Dimerix Says First 100 Patients Enrolled in Phase 3 Kidney Disease Clinical Trial Complete Two-Year Double-Blind Treatment Period	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes